Name: Latest research reports of Divi's Laboratories Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 1
Author: Karvy

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

6023.5000 -124.50 (-2.03%)

NSE May 08, 2025 12:46 PM

Near 52W High of ₹6308.50

Volume: 139.4K

Divi's Laboratories Ltd.

06 Nov 2019

6023.50

-2.03%

Divi s Lab: Lower margins on account of product mix

Sell: Divi's Laboratories Ltd.

Recommendation Target

Karvy

Divis Lab s Net revenues increased by 9.2 percent YoY to Rs 14.45 bn, which ishigher than our estimates.

Divi's Laboratories .. has an average target of 5832.12 from 9 brokers.